Rona Therapeutics announces IND filing of RN3161 for obesity EP News Bureau Sep 16, 2025 Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced the successful submission of RN3161…
Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData EP News Bureau Sep 5, 2023 The latest data from the final analysis of the Phase II OCEAN(a)-DOSE study showed that olpasiran reduced Lp(a) levels in patients…
